Year: 2023

Theriva Biologics Announces Presentation of Data from Cohort 1 of the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

- Interim blinded safety and pharmacokinetic data to be presented at the 33rd European Congress of Clinical Microbiology & Infectious...

BioAdaptives Inc. (OTC BDPT) Announces New Appointment to the Board of Directors – Visionary Futurist , Wellness Pioneer and Marketer, David Allen, PhD

LAS VEGAS, NV, April 13, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today the appointment...

CLS Americas Announces Research Collaboration with the National Institutes of Health Clinical Center to Study MRI/Ultrasound Fusion-Guided FLA of Prostate Tissue and Prostate Cancer

IRVINE, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser...

Celularity’s Dr. Robert Hariri To Co-Chair The 2023 International Precision Medicine Center (IPMC) Conference “Beyond Longevity: Live 120 Like 50™”

Hariri, Celularity’s CEO, Chairman and Founder, will open the meeting with the keynote address highlighting recent progress and important next...

error: Content is protected !!